BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8186337)

  • 1. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
    Michel P; Lemaire M; Colin R; Bommelaer G; Rambaud JC; Dupas JL; Bigard MA; Verwaerd JC
    Aliment Pharmacol Ther; 1994 Feb; 8(1):119-22. PubMed ID: 8186337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
    Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
    Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid healing of gastric ulcers with lansoprazole.
    Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
    Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
    Robinson M; Sahba B; Avner D; Jhala N; Greski-Rose PA; Jennings DE
    Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
    Londong W; Barth H; Dammann HG; Hengels KJ; Kleinert R; Müller P; Rohde H; Simon B
    Aliment Pharmacol Ther; 1991 Jun; 5(3):245-54. PubMed ID: 1888824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
    Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
    Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
    Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
    Brunner G; Arnold R; Hennig U; Fuchs W
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.
    Nishina K; Mikawa K; Takao Y; Shiga M; Maekawa N; Obara H
    Anesth Analg; 2000 Mar; 90(3):717-21. PubMed ID: 10702463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
    Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
    Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.
    Mathias SD; Colwell HH; Miller DP; Pasta DJ; Henning JM; Ofman JJ
    Dig Dis Sci; 2001 Nov; 46(11):2416-23. PubMed ID: 11713946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.
    Kovacs TO; Campbell D; Haber M; Rose P; Jennings DE; Richter J
    Dig Dis Sci; 1998 Apr; 43(4):779-85. PubMed ID: 9558034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.